1Consideration in top-level design and conduct of clinical study systems in China1209-12162Advices on improving clinical research regulatory system in China1217-12243Current difficulties and challenges during the design and conduct stages of clinical trials in China1225-12324Study on classification system of pharmaceutical patentsMING Zhi-hui, HUANG Wen-jie, LIU Cai-lian, TAN Ai-min, LUO Wei-jia, REN Jin-sheng1233-12375Introduction of ICH E17 General Principle on Planning and Designing Multi-Regional Clinical Trials from clinical considerationYANG Huan, JI Shuang-min, GAO Chen-yan, ZHOU Si-yuan, XU Jia-qi1238-12446Considerations about the requirements to the pediatric population clinical trials according to the new classification of chemical drugsGENG Ying, ZHAO Deng-heng, YANG Zhi-min1245-12487Several thoughts on accepting non-registered clinical trials in IND registration evaluationGAO Jian-chao, WEI Wei, HUANG Yun-hong, YANG Huan, GAO Chen-yan1249-12538Design and quality control of traditional Chinese medicine formula placebo for the clinical trialsWU Fei, LU Zhang-qi, HU Jia-liang, WU Mei, FENG Yi, ZHANG Ji-quan, WANG You-jie1254-12619New requirements for statistics of clinical trial by ICH E9 (R1)YAN Xiao-yan, YAO Chen1262-126510Cultural environment and development of CRC and SMO in ChinaLI Shu-ting, LIU Yang, GAO Zhi-gang, WANG Yue, HU Si-jia, XIONG Meng-zhen, GAO Li-xin, WANG Zhe-yuan, GUI Shang-yuan, SUO Wei, LIU Yan-fei, YANG Li, WANG Xin, REN Ke1266-127211Drug clinical trial data inspection and common problems analysisWANG Jia-nan, QIAN Xue, LI Jian-ming1273-127612Study on quality risk management in the implementation stage of bioequivalence test of clinical trial institutionLI Jiang-fan, LI Ke-xin, WU Zhi-ang1277-128213Application of ethics review information management system in implement and monitor for clinical trialsCAO Jiang, LIANG Bei-bei, BAI Nan, XU Fang, CAI Yun, WANG Rui, WANG Jin1283-128514History and current situation of multi-regional clinical trial in ChinaZHANG Xiao-fang, WU Yang-feng1286-128915Consideration of ethical collaborative review of multi-center clinical trialsHUANG Xu, WANG Xiu-qin1290-129316Interpretation and future outlook of joint ethical review consensus in China Forums of Clinical Research Capacity Building and Human Research Participants Protection (CCHRPP)XU Zhong-yuan1294-129817Strengthen the management of human genetic resources in drug clinical trialsWANG Li-jue, WU Ming-feng, WANG Dan-lei, FAN Hua-ying, XIE Zhen-wei, ZHANG Hua, WANG Hao1299-130218Construction and management practice of drug clinical trial institution in a grade Ⅲ hospitalZHAO Shan-shan, LIU Yang, LI Jing1303-130819Comparison of the anti-inflammatory activity of Huangqin dispensing granules and Huangqin standard decoctionHAO Cui, DUAN Wen-juan, ZHAO Heng-qiang, DONG Hong-jing, LIU Feng-qin, ZHANG Yu-jie, WANG Xiao, MU Yan1309-131420Study on identification of liquiritigenin-producing endophytic fungus GJZ21 from Glycyrrhiza uralensis and its activitiesMENG Li, ZHENG Xue, WANG Yu-qing, ZHANG Ping, ZHENG Chun-ying1315-1320 